ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $817,422 | +42.2% | 402,671 | +61.1% | 0.01% | +20.0% |
| Q2 2023 | $575,000 | -24.1% | 250,000 | 0.0% | 0.01% | -33.3% |
| Q1 2023 | $757,500 | +29.5% | 250,000 | -0.4% | 0.02% | +50.0% |
| Q4 2022 | $585,063 | +30.6% | 251,100 | +7.4% | 0.01% | +42.9% |
| Q3 2022 | $448,000 | -63.3% | 233,784 | -48.1% | 0.01% | -56.2% |
| Q2 2022 | $1,222,000 | -50.0% | 450,800 | -45.0% | 0.02% | -44.8% |
| Q1 2022 | $2,442,000 | +71.6% | 819,080 | +124.3% | 0.03% | +70.6% |
| Q4 2021 | $1,423,000 | +183.5% | 365,097 | +212.3% | 0.02% | +183.3% |
| Q3 2021 | $502,000 | -30.7% | 116,898 | -51.0% | 0.01% | -40.0% |
| Q2 2021 | $724,000 | +189.6% | 238,700 | +267.2% | 0.01% | -50.0% |
| Q4 2018 | $250,000 | – | 65,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |